“… 2 Human cells with RTEL1 mutations exhibit rapid telomere shortening, proliferative exhaustion, increased senescence, and spontaneous apoptosis. Phenotypically, RTEL1 mutations are known to be associated with a host of genetic diseases and disorders, including dyskeratosis congenita (DC) and its severe variant, Hoyeraal–Hreidarsson syndrome (HHs), 3 , 4 , 5 bone marrow failure (BMF), 3 , 4 , 5 , 6 , 7 very early‐onset monogenic inflammatory bowel disease (IBD) and IBD‐like colitis, 5 , 8 , 9 pulmonary fibrosis, 3 , 4 , 10 , 11 , 12 , 13 liver disease 4 , 14 and myeloid neoplasms. 7 , 14 , 15 , 16 Several RTEL1 mutants are also associated with an increased risk of glioma.…”